These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5464664)

  • 1. [Electroencephalographic effects of atropine and scopolamine].
    Narumi S; Suzuki Y; Hano K
    Yakugaku Zasshi; 1970 Jun; 90(6):651-60. PubMed ID: 5464664
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and electroencephalographic effects of atropine and related compounds.
    Longo VG
    Pharmacol Rev; 1966 Jun; 18(2):965-96. PubMed ID: 5328390
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of atropine and related drugs on the EEG and behaviour.
    Bradley PB
    Prog Brain Res; 1968; 28():3-13. PubMed ID: 4301741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of M- and N-central cholinolytics on the correlation between behavorial and electroencephalographic reactions of the ascending activating system of the brain stem].
    Krauz VA
    Farmakol Toksikol; 1968; 31(4):391-4. PubMed ID: 4386983
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of atropine and scopolamine upon electroencephalographic changes induced by electro-convulsive-therapy.
    ULETT GA; JOHNSON MW
    Electroencephalogr Clin Neurophysiol; 1957 May; 9(2):217-24. PubMed ID: 13414645
    [No Abstract]   [Full Text] [Related]  

  • 6. The convulsant effect of topically applied atropine.
    Daniels JC; Spehlmann R
    Electroencephalogr Clin Neurophysiol; 1973 Jan; 34(1):83-7. PubMed ID: 4118441
    [No Abstract]   [Full Text] [Related]  

  • 7. An examination of central actions characteristic of scopolamine: comparison of central and peripheral activity in scopolamine, atropine and some synthetic basic esters.
    Aparkes MW
    Psychopharmacologia; 1965 Jan; 7(1):1-19. PubMed ID: 5830966
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 9. Atropine, scopolamine and hippocampal lesion effects on alternation performance of rats.
    White SR
    Pharmacol Biochem Behav; 1974 May; 2(3):297-307. PubMed ID: 4837901
    [No Abstract]   [Full Text] [Related]  

  • 10. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of certain central effects of atropine, scopolamine and their quaternary ammonium derivatives in animals].
    Malatray J; Simon P
    Therapie; 1972; 27(1):153-66. PubMed ID: 5017551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Central effects of anisodamine, atropine, anisodine and scopolamine after intraventricular injection].
    Peng JZ; Jin LR; Chen XY; Chen ZX
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):81-7. PubMed ID: 6225308
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of atropine and eserine on the episodic behavioral and electrographic manifestations induced by methionine sulfoximine.
    Wada JA; Ikeda H
    Exp Neurol; 1966 Dec; 16(4):450-63. PubMed ID: 5957204
    [No Abstract]   [Full Text] [Related]  

  • 14. Models for scopolamine, atropine and amphetamine effects on an alternate bar pressing paradigm.
    Reilly KD
    Bull Math Biophys; 1967 Dec; 29(4):767-79. PubMed ID: 5582154
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of atropine, scopolamine and benactyzine on the physostigmine arousal reaction in rabbits.
    Votava Z; Benesová O; Bohdanecký Z; Grofová O
    Prog Brain Res; 1968; 28():40-7. PubMed ID: 5699590
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory responses to transmural stimulation in isolated intestinal preparations.
    Day MD; Warren PR
    J Pharm Pharmacol; 1967 Jun; 19(6):408-10. PubMed ID: 4382375
    [No Abstract]   [Full Text] [Related]  

  • 17. Central and peripheral effects of anticholinergic compounds.
    Albanus L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(4):305-26. PubMed ID: 5536020
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic mechanism determines the occurrence of reward contingent positive variation (RCPV) in cat.
    Marczynski TJ
    Brain Res; 1971 Apr; 28(1):71-83. PubMed ID: 5557886
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spasmolytic effect of 5,5-diphenyl-2-(2'-piperidino-ethyl)-1,3-dioxclan-4-one HCl, a new spasmolytic].
    Mörsdorf K; Wengenroth H; Pailer M
    Arzneimittelforschung; 1969 Nov; 19(11):1855-60. PubMed ID: 4391791
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in hippocampal and cortical EEG after intraventricular administration of cholinolytics in rabbit and cat.
    Gralewicz S; Gralewicz K
    Acta Neurobiol Exp (Wars); 1988; 48(6):323-34. PubMed ID: 3251407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.